SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 184 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $713,730 | -54.3% | 1,189,947 | -1.0% | 0.00% | – |
| Q2 2023 | $1,562,560 | -28.9% | 1,201,969 | -3.7% | 0.00% | – |
| Q1 2023 | $2,196,505 | -45.7% | 1,248,014 | -3.0% | 0.00% | -100.0% |
| Q4 2022 | $4,041,691 | -32.1% | 1,287,163 | +6.0% | 0.00% | 0.0% |
| Q3 2022 | $5,950,000 | +23.3% | 1,214,201 | +4.1% | 0.00% | 0.0% |
| Q2 2022 | $4,827,000 | -30.7% | 1,165,831 | -2.8% | 0.00% | 0.0% |
| Q1 2022 | $6,968,000 | -24.9% | 1,199,238 | -3.1% | 0.00% | -50.0% |
| Q4 2021 | $9,277,000 | -29.2% | 1,237,066 | -15.0% | 0.00% | 0.0% |
| Q3 2021 | $13,109,000 | -26.6% | 1,454,997 | -2.4% | 0.00% | -33.3% |
| Q2 2021 | $17,853,000 | +5.7% | 1,491,442 | +10.6% | 0.00% | 0.0% |
| Q1 2021 | $16,894,000 | -24.8% | 1,348,202 | -6.4% | 0.00% | -25.0% |
| Q4 2020 | $22,477,000 | +59.6% | 1,440,320 | -3.3% | 0.00% | +33.3% |
| Q3 2020 | $14,080,000 | -0.2% | 1,489,948 | -5.4% | 0.00% | 0.0% |
| Q2 2020 | $14,107,000 | +52.4% | 1,574,507 | +8.4% | 0.00% | 0.0% |
| Q1 2020 | $9,256,000 | -26.5% | 1,453,042 | -3.4% | 0.00% | 0.0% |
| Q4 2019 | $12,593,000 | -8.1% | 1,504,607 | -0.7% | 0.00% | 0.0% |
| Q3 2019 | $13,708,000 | -7.3% | 1,514,732 | +10.3% | 0.00% | -25.0% |
| Q2 2019 | $14,793,000 | +17.3% | 1,373,469 | +3.9% | 0.00% | +33.3% |
| Q1 2019 | $12,615,000 | -16.8% | 1,322,332 | +0.1% | 0.00% | -25.0% |
| Q4 2018 | $15,171,000 | -32.3% | 1,321,511 | -0.1% | 0.00% | -20.0% |
| Q3 2018 | $22,425,000 | +22.6% | 1,322,966 | +2.7% | 0.01% | 0.0% |
| Q2 2018 | $18,286,000 | -9.5% | 1,287,800 | +21.0% | 0.01% | 0.0% |
| Q1 2018 | $20,215,000 | +16.2% | 1,063,930 | +0.3% | 0.01% | +25.0% |
| Q4 2017 | $17,400,000 | +8.5% | 1,060,932 | -0.8% | 0.00% | 0.0% |
| Q3 2017 | $16,037,000 | +92.3% | 1,069,095 | +12.8% | 0.00% | +100.0% |
| Q2 2017 | $8,341,000 | +77.6% | 947,832 | +4.9% | 0.00% | +100.0% |
| Q1 2017 | $4,697,000 | +72.5% | 903,176 | +1.2% | 0.00% | 0.0% |
| Q4 2016 | $2,723,000 | -33.5% | 892,776 | +0.9% | 0.00% | 0.0% |
| Q3 2016 | $4,097,000 | -19.5% | 884,870 | +0.6% | 0.00% | -50.0% |
| Q2 2016 | $5,092,000 | -0.4% | 879,456 | +4.1% | 0.00% | 0.0% |
| Q1 2016 | $5,110,000 | -32.2% | 844,684 | +2.3% | 0.00% | 0.0% |
| Q4 2015 | $7,539,000 | +65.4% | 825,736 | +2.2% | 0.00% | 0.0% |
| Q3 2015 | $4,558,000 | -47.7% | 808,312 | +2.8% | 0.00% | -33.3% |
| Q2 2015 | $8,716,000 | -29.9% | 785,933 | -1.0% | 0.00% | -25.0% |
| Q1 2015 | $12,442,000 | +5.0% | 793,490 | +1.9% | 0.00% | 0.0% |
| Q4 2014 | $11,847,000 | +35.5% | 778,857 | -3.9% | 0.00% | +33.3% |
| Q3 2014 | $8,742,000 | -32.8% | 810,524 | -4.8% | 0.00% | -25.0% |
| Q2 2014 | $13,002,000 | -16.5% | 851,494 | -1.1% | 0.00% | -20.0% |
| Q1 2014 | $15,573,000 | +21.8% | 861,346 | -6.4% | 0.01% | +25.0% |
| Q4 2013 | $12,783,000 | +46.7% | 920,277 | +10.8% | 0.00% | +33.3% |
| Q3 2013 | $8,714,000 | +36.1% | 830,676 | +1.3% | 0.00% | +50.0% |
| Q2 2013 | $6,402,000 | – | 819,757 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |